These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2583907)

  • 1. Diflucortolone valerate ointment with and without occlusion in lichen simplex chronicus.
    Geraldez MC; Carreon-Gavino M; Hoppe G; Costales A
    Int J Dermatol; 1989 Nov; 28(9):603-4. PubMed ID: 2583907
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus.
    Brunner N; Yawalkar S
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1160-3. PubMed ID: 1757609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biologic availability of diflucortolone-21-valerate in human skin].
    Täuber U
    Arzneimittelforschung; 1983; 33(10):1503-7. PubMed ID: 6686053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of 0.3% diflucortolone valerate in the topical treatment of steroid-sensitive dermatitis].
    Jucci A; Fideli D; Speziali A
    G Ital Dermatol Venereol; 1986; 121(6):LXXVII-LXXX. PubMed ID: 3549546
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of diflucortolone. Preliminary report].
    Hernańdez-Peŕez E
    Med Cutan Ibero Lat Am; 1981; 9(3):229-32. PubMed ID: 7026942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diflucortolone valerate. Asian experience.
    Hoppe G
    Drugs; 1988; 36 Suppl 5():24-33. PubMed ID: 3254827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diflucortolone valerate and chlorquinaldol in topical eczema (in single or combination form)].
    Solaroli C; Sgarbanti E
    G Ital Dermatol Venereol; 1987 May; 122(5):XXXI-XXXIII. PubMed ID: 3623611
    [No Abstract]   [Full Text] [Related]  

  • 10. A test of the half-side comparative design in the clinical evaluation of topical steroids, using diflucortolone and betamethasone creams.
    August PJ; Platt NE; Wiseman RA
    Br J Clin Pract; 1985 Oct; 39(10):383-7. PubMed ID: 3907679
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
    Coleman GL; Kanfer I; Haigh JM
    Dermatologica; 1978; 156(4):224-30. PubMed ID: 342295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
    Reckers R; Wendt H
    Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are topical corticoids advantageous and justifiable in the treatment of dermatomycoses? (Travocort cream and Travogen cream were compared in 100 patients in an interindividual double-blind trial) (author's transl)].
    Nolting S; Langen ML
    Mykosen; 1980 Dec; 23(12):699-706. PubMed ID: 7012612
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diflucortolone-21-valerate Reference Standard (Control 871) of National Institute of Hygienic Sciences].
    Tanaka M; Hiroshige R; Murai M; Tokunaga H; Okada S; Kimura T
    Eisei Shikenjo Hokoku; 1989; (107):156-9. PubMed ID: 2636922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of tinea pedis with a topical agent containing isoconazole nitrate and diflucortolone valerate.
    Kye YC
    Mycoses; 2008 Sep; 51 Suppl 4():48-9. PubMed ID: 18783570
    [No Abstract]   [Full Text] [Related]  

  • 16. The effective use of isoconazole nitrate and diflucortolone valerate cream in the treatment of inguino-femoral skin fold mycosis.
    Kotrekhova LP
    Mycoses; 2008 Sep; 51 Suppl 4():29-31. PubMed ID: 18783562
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of candidal intertrigo with a topical combination of isoconazole nitrate and diflucortolone valerate.
    Dogan B; Karabudak O
    Mycoses; 2008 Sep; 51 Suppl 4():42-3. PubMed ID: 18783567
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative multicentre trial of halometasone/triclosan cream and diflucortolone valerate/chlorquinaldol cream in the treatment of acute dermatomycoses.
    Maeder E; Schindléry C; Macarol V; Schoenenberger PM
    J Int Med Res; 1983; 11 Suppl 1():48-52. PubMed ID: 6339293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Croton oil-induced hemorrhoid model in rat: comparison of anti-inflammatory activity of diflucortolone valerate with other glucocorticoids].
    Nishiki K; Nishinaga K; Kudoh D; Iwai K
    Nihon Yakurigaku Zasshi; 1988 Oct; 92(4):215-25. PubMed ID: 3243508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma secondary to topical use of steroid cream.
    thoe Schwartzenberg GW; Buys YM
    Can J Ophthalmol; 1999 Jun; 34(4):222-5. PubMed ID: 10396659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.